Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bloomfield

Showing results (571-580 of 583) with videos related to

Pageof 59
Sort By:
Leukemia|March 3, 2021
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trialRichard A Larson, Sumithra J Mandrekar, Lucas J Huebner, et al.
Leukemia|May 11, 2019
Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR studyCelalettin Ustun, Jennifer Le-Rademacher, Hai-Lin Wang, et al.
Blood Advances|October 13, 2020
Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trialMaria Teresa Voso, Richard A Larson, Dan Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in AdultsKathryn G Roberts, Zhaohui Gu, Debbie Payne-Turner, et al.
Blood|December 12, 2019
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemiaKonstanze Döhner, Christian Thiede, Nikolaus Jahn, et al.
Blood|December 4, 2014
A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adultsVirginia Perez-Andreu, Kathryn G Roberts, Heng Xu, et al.
Cancer Medicine|August 18, 2018
Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)Celalettin Ustun, Elizabeth Morgan, Erica E M Moodie, et al.
Blood Advances|May 18, 2021
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)Se Young Han, Krzysztof Mrózek, Jenna Voutsinas, et al.
Nature Communications|November 9, 2016
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemiaZhaohui Gu, Michelle Churchman, Kathryn Roberts, et al.
Nature Genetics|January 16, 2019
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemiaZhaohui Gu, Michelle L Churchman, Kathryn G Roberts, et al.
Pageof 59

Showing results (571-580 of 583) with videos related to

Sort By:
Pageof 59
Leukemia|March 3, 2021
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trialRichard A Larson, Sumithra J Mandrekar, Lucas J Huebner, et al.
Leukemia|May 11, 2019
Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR studyCelalettin Ustun, Jennifer Le-Rademacher, Hai-Lin Wang, et al.
Blood Advances|October 13, 2020
Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trialMaria Teresa Voso, Richard A Larson, Dan Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in AdultsKathryn G Roberts, Zhaohui Gu, Debbie Payne-Turner, et al.
Blood|December 12, 2019
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemiaKonstanze Döhner, Christian Thiede, Nikolaus Jahn, et al.
Blood|December 4, 2014
A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adultsVirginia Perez-Andreu, Kathryn G Roberts, Heng Xu, et al.
Cancer Medicine|August 18, 2018
Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)Celalettin Ustun, Elizabeth Morgan, Erica E M Moodie, et al.
Blood Advances|May 18, 2021
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)Se Young Han, Krzysztof Mrózek, Jenna Voutsinas, et al.
Nature Communications|November 9, 2016
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemiaZhaohui Gu, Michelle Churchman, Kathryn Roberts, et al.
Nature Genetics|January 16, 2019
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemiaZhaohui Gu, Michelle L Churchman, Kathryn G Roberts, et al.
Pageof 59